
News|Articles|November 20, 2024
Beyond the Checkbox: How Rethinking Your Cardiac Monitoring Approach Can Dramatically Improve Trial Outcomes
Author(s)AliveCor
AliveCor knows that cardiac safety is critical, with concerns often driving drug withdrawals from trials and the market. Our solutions go beyond compliance to boost regulatory trust, data integrity, and trial success. As the only company offering integrated 6L and 12L ECGs, we provide comprehensive monitoring—onsite and remotely—to meet complex cardiac requirements. Our innovative tools empower sponsors and CROs to control trial data, enabling faster, smarter decisions throughout the research lifecycle.
Trending on Applied Clinical Trials Online
1
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
2
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
3
Vaccine Trials at an Inflection Point: Operational, Regulatory, and Public Trust Challenges
4
What Real-Time Data Review Actually Demands of Sponsors and CROs
5